Ironwood Pharmaceuticals reported $7.84M in Interest Expense on Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Alnylam Pharmaceuticals ALNY:US $ 40.27M 6.86M
Amarin AMRN:US $ 0.39M 0.36M
Ardelyx ARDX:US $ 1.22M 0.01M
Charles River Laboratories CRL:US $ 16.45M 0.26M
Coherus Biosciences CHRS:US $ 5.77M 0.02M
Emergent Biosolutions EBS:US $ 8.4M 0.2M
Esperion Therapeutics ESPR:US $ 13.65M 2.51M
Exact Sciences EXAS:US $ 4.68M 0.03M
Flexion Therapeutics FLXN:US $ 6.29M 1.11M
Halozyme Therapeutics HALO:US $ 1.75M 0M
Intercept Pharmaceuticals ICPT:US $ 14.1M 1.51M
Ironwood Pharmaceuticals IRWD:US $ 7.84M 0.11M
Karyopharm Therapeutics KPTI:US $ 8.01M 3.01M
Lexicon Pharmaceuticals LXRX:US 171K 2K
Moderna Inc MRNA:US 4M 1000K
Myriad Genetics MYGN:US $ 1.1M 0.9M
Pacira Pharmaceuticals PCRX:US $ 7.33M 0.31M
Ptc Therapeutics PTCT:US $ 21.8M 0.76M
Puma Biotechnology PBYI:US $ 3.12M 0.4M
Sarepta Therapeutics SRPT:US $ 16M 0.16M
YTE INCY:US $ 0.44M 0.08M